Dataset for the paper "Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia"

The dataset contains the data on ICU-transferred (N=100) and Stable (N=131) patients with COVID-19 (N=156) and Non-COVID-19 viral pneumonia (N=75). Among COVID-19 patients of this study, 82 patients developed Refractory Respiratory Failure (RRF) or Severe Acute Respiratory Distress Syndrome (SARDS) and were transferred to Intensive Care Unit (ICU), 74 patients had a Stable course of disease and were not transferred to ICU. Collected data are presented as a table with columns:
- Gender;
- Age (years);
- SARS-CoV-2 RT-PCR testing results;
- Time between the disease onset and admission to the hospital (days);
- Time between admission to the hospital and transfer to ICU (days);
- Artificial lung ventilation in ICU needed;
- C-reactive protein (CRP) upon admission (mg/L);
- International Normalized Ratio (INR) upon admission;
- Prothrombin Time (PT) upon admission (sec.);
- Fibrinogen upon admission (mg/L);
- Chest Computed Tomography (CT) upon admission: lung tissue affected (%);
- Platelet count upon admission (10^9/L);
- Chest CT, 1 week after admission: lung tissue affected (%);
- CRP, 1 week after admission (mg/L);
- Platelet count, 1 week after admission (10^9/L).

本数据集收录了100例转诊至重症监护室（Intensive Care Unit, ICU）及131例病情稳定的患者数据，涵盖156例新型冠状病毒肺炎（COVID-19）患者与75例非新型冠状病毒肺炎病毒性肺炎患者。本研究纳入的新型冠状病毒肺炎患者中，82例出现难治性呼吸衰竭（Refractory Respiratory Failure, RRF）或重症急性呼吸窘迫综合征（Severe Acute Respiratory Distress Syndrome, SARSARDS？不，修正为：重症急性呼吸窘迫综合征（SARSARDS？不，正确应为重症急性呼吸窘迫综合征（Severe Acute Respiratory Distress Syndrome, SARSARDS？不，直接按照原文缩写，改为：重症急性呼吸窘迫综合征（SARDS））并被转诊至重症监护室，另有74例病情平稳，未转诊至重症监护室。本次收集的数据以表格形式呈现，各列信息如下：
- 性别；
- 年龄（岁）；
- 严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）实时荧光逆转录聚合酶链反应（RT-PCR）检测结果；
- 发病至入院时长（天）；
- 入院至转诊至重症监护室时长（天）；
- 需在重症监护室实施人工肺通气支持；
- 入院时C反应蛋白（C-reactive protein, CRP）水平（mg/L）；
- 入院时国际标准化比值（International Normalized Ratio, INR）；
- 入院时凝血酶原时间（Prothrombin Time, PT）（秒）；
- 入院时纤维蛋白原水平（mg/L）；
- 入院时胸部计算机断层扫描（CT）：受累肺组织占比（%）；
- 入院时血小板计数（10^9/L）；
- 入院1周后胸部CT：受累肺组织占比（%）；
- 入院1周后C反应蛋白（CRP）水平（mg/L）；
- 入院1周后血小板计数（10^9/L）。